Zoetis Inc (ZTS) Stock Price Today
Aura AI Summary
Key Stats
- $30.71BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $159.18FIFTY_TWO_WEEK_HIGH
- $71.91FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $38.01BENTERPRISE_VALUE
- 2.83%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Zoetis Inc (ZTS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Zoetis Inc has traded between a low of $71.91 and a high of $159.18, highlighting its annual price range. Buy and sell Zoetis Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Most Recent News
Halper Sadeh LLC probes fairness of major company sales for shareholders' benefit.
Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...

Europe approves TEPKINLY combo for relapsed follicular lymphoma, offering a chemo-free treatment option.
The European Commission has approved TEPKINLY (epcoritamab) combined with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma in adults. This marks the first bispecific antibody-based therapy authorized in Europe for se...

Class action deadlines approach for investors in BTGO, VIA, Z, and ADMA over alleged securities fraud.
Law Offices of Howard G. Smith has announced upcoming deadlines for investors to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege that the compani...
